Information Provided By: 
Fly News Breaks for September 11, 2015
ZTS
Sep 11, 2015 | 08:30 EDT
BMO Capital upgraded Zoetis based on valuation and its belief that the company's market can continue to grow at an approximately 5% rate over the longer term, driven by increased consumption of protein and increased spending on pets. BMO says the company is unlikely to face "disruptive competition," and should grow in-line with its market.
News For ZTS From the Last 2 Days
ZTS
Apr 23, 2024 | 05:05 EDT
Barclays lowered the firm's price target on Zoetis to $230 from $260 and keeps an Overweight rating on the shares ahead of the Q1 report. The analyst expects the Q1 reports to provide continuing evidence of improvement in generics and biosimilars for the specialty pharmaceuticals group.
